Mechanism-informed development of EphA2 PET imaging for noninvasive target assessment in triple-negative breast cancer

Triple-negative breast cancer (TNBC) exhibits marked spatial heterogeneity and variable sensitivity to immune checkpoint blockade, creating a need for whole-body biomarkers of immune-relevant tumor states. Here, tumor-cell EphA2 is identified as implicated in an immune-restricted TNBC phenotype. Human transcriptomic and spatial analyses, together with immunocompetent tumor models, show that EphA2 is associated with aggressive malignant-cell states, reduced CD8 + T-cell infiltration and effector function, and limited responsiveness to PD-1 blockade. Mechanistic analyses linked EphA2 to a CD73-related AMP-to-adenosine program accompanied by coordinated changes in AKT/mTOR–HIF-1α signaling, whereas CD73 re-expression attenuated several tumor and immune phenotypes associated with Epha2 knockdown. Guided by this biology, two gallium-68-labeled EphA2-targeting bicyclic peptide radiotracers are compared through AI-assisted computational evaluation and experimental validation. The FZEAR11 precursor showed stronger measured EphA2 affinity than FZEAR12, while [ 68 Ga]Ga-FZEAR11 exhibited higher cellular and tumor uptake, rapid blood clearance, and superior tumor-to-muscle contrast relative to [ 68 Ga]Ga-FZEAR12. Blocking studies and EphA2-high versus EphA2-low models support a substantial target-associated and saturable component of tumor accumulation. Exploratory first-in-human PET/CT in three patients demonstrates same-day visualization of pathologically confirmed, EphA2-expressing TNBC lesions against a low soft-tissue background. These findings establish a mechanism-informed strategy for EphA2 PET and support further evaluation of [ 68 Ga]Ga-FZEAR11 for whole-body target assessment in TNBC.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-16
DOI
https://doi.org/10.1186/s12951-026-05267-4
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mechanism-informed development of EphA2 PET imaging for noninvasive target assessment in triple-negative breast cancer

李盼丽, Simin He, 许小平, Shaoli Song et al.
3 links
Journal of Nanobiotechnology
Radiopharmaceutical Chemistry and Applications
article

Mechanism-informed development of EphA2 PET imaging for noninvasive target assessment in triple-negative breast cancer

李盼丽, Simin He, 许小平, Shaoli Song, Haoyao Guo, Linjie Bian, Xuan Huang, Xiangwei Wang, Jianping Zhang
article en

Abstract

Triple-negative breast cancer (TNBC) exhibits marked spatial heterogeneity and variable sensitivity to immune checkpoint blockade, creating a need for whole-body biomarkers of immune-relevant tumor states. Here, tumor-cell EphA2 is identified as implicated in an immune-restricted TNBC phenotype. Human transcriptomic and spatial analyses, together with immunocompetent tumor models, show that EphA2 is associated with aggressive malignant-cell states, reduced CD8 + T-cell infiltration and effector function, and limited responsiveness to PD-1 blockade. Mechanistic analyses linked EphA2 to a CD73-related AMP-to-adenosine program accompanied by coordinated changes in AKT/mTOR–HIF-1α signaling, whereas CD73 re-expression attenuated several tumor and immune phenotypes associated with Epha2 knockdown. Guided by this biology, two gallium-68-labeled EphA2-targeting bicyclic peptide radiotracers are compared through AI-assisted computational evaluation and experimental validation. The FZEAR11 precursor showed stronger measured EphA2 affinity than FZEAR12, while [ 68 Ga]Ga-FZEAR11 exhibited higher cellular and tumor uptake, rapid blood clearance, and superior tumor-to-muscle contrast relative to [ 68 Ga]Ga-FZEAR12. Blocking studies and EphA2-high versus EphA2-low models support a substantial target-associated and saturable component of tumor accumulation. Exploratory first-in-human PET/CT in three patients demonstrates same-day visualization of pathologically confirmed, EphA2-expressing TNBC lesions against a low soft-tissue background. These findings establish a mechanism-informed strategy for EphA2 PET and support further evaluation of [ 68 Ga]Ga-FZEAR11 for whole-body target assessment in TNBC.

Journal of Nanobiotechnology
Shanghai Medical College of Fudan University (CN), Fudan University (CN), Fudan University Shanghai Cancer Center (CN), Shanghai University of Medicine and Health Sciences (CN)
Natural Science Foundation of Shanghai, National Natural Science Foundation of China, China Postdoctoral Science Foundation, Shanghai Key Laboratory of Molecular Imaging
Good health and well-being
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon